Uncategorized
Neoadjuvant intra-arterial cytoreductive chemotherapy may improve survival in patients with lacrimal gland adenoid cystic carcinoma
Patients with lacrimal gland adenoid cystic carcinoma may be treated with neoadjuvant intra-arterial cytoreductive chemotherapy instead of conventional treatment for improved survival, according to a study.The retrospective case series included 19 consecutive patients treated with intra-arterial cytoreductive chemotherapy. Disease relapse, disease-free survival and chemotherapeutic complications were all measured.